EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Combined [18F]-FDG PET-MR imaging for monitoring small bowel crohn’s disease

Juho Mattila iD, Johanna Kallio, Eliisa Löyttyniemi, Pirjo Nuutila, Jukka Koffert

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07524-4 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Juho Mattila und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Turku University Hospital, P.O. Box 52, Turku, 20521, Finland. juho.mattila@varha.fi. Hauptthemen laut MEDLINE: Crohn Disease, Fluorodeoxyglucose F18, Intestine, Small, Magnetic Resonance Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Turku.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Crohn’s disease (CD) is a chronic and relapsing inflammatory disease of the gastrointestinal tract. Diagnostics and follow-up are difficult in small bowel, that can be only partially evaluated by conventional endoscopy. Combined positron emission tomography magnetic resonance enterography (PET-MRE) has shown potential in diagnosing small bowel CD, but its role in monitoring treatment response has not been previously established. This study aimed to evaluate whether PET-MRE can be used to assess the efficacy of medical therapy. We hypothesized that standardized uptake values (SUV) in inflamed small bowel segments would decrease following initiation of standard therapy. A total of 35 volunteer patients with clinically suspected small bowel CD were recruited. All patients underwent ileocolonoscopy and laboratory testing, followed by [ 18 F]-FDG PET-MRE. CD diagnosis was confirmed by small bowel capsule endoscopy. Clinicians initiated treatment based on standard diagnostics, blinded to the PET results. Eighteen patients completed follow-up [ 18 F]-FDG PET-MRE at three months. Maximum SUV (SUV Max ) was measured in the small intestine and compared with MRE findings. The median SUV Max decreased significantly from baseline to follow-up (3.2 vs. 2.1, p = 0.0025). The Simplified Magnetic Resonance Index of Activity (sMARIA) was also significantly lower at follow-up ( p = 0.001). Representatively, median fecal calprotectin declined (451 µg/g vs. 163 µg/g, p = 0.004). This preliminary prospective study suggests that [ 18 F]-FDG PET-MRE may be a useful tool for assessing biochemical response to treatment in newly diagnosed small bowel CD. Trial registration number: NCT06796959 (ClinicalTrials.gov). Retrospectively registered on 21.1.2025. Enrollment of first participant on 1.8.2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Crohn DiseaseFluorodeoxyglucose F18Intestine, SmallMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyAdultFemaleHumansMaleMiddle AgedYoung Adult

Stichwörter der Autor:innen

Crohn’s diseaseDiagnosticsFDGIBDPET-MRI

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Gastroenterology, Turku University Hospital, P.O. Box 52, Turku, 20521, Finland. juho.mattila@varha.fi.
  • Department of Radiology, Turku University Hospital, Turku, Finland.
  • Department of Biostatistics, University of Turku, Turku, Finland.
  • Turku PET Center, University of Turku, Turku, Finland.
  • Department of Gastroenterology, Turku University Hospital, P.O. Box 52, Turku, 20521, Finland.

ORCID-Profile: Juho Mattila

Förderung

  • University of Turku

Zitieren

APA

Mattila, J., Kallio, J., Löyttyniemi, E., Nuutila, P., & Koffert, J. (2026). Combined [18F]-FDG PET-MR imaging for monitoring small bowel crohn’s disease. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07524-4

Vancouver

Mattila J, Kallio J, Löyttyniemi E, Nuutila P, Koffert J. Combined [18F]-FDG PET-MR imaging for monitoring small bowel crohn’s disease. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07524-4

BibTeX
@article{Mattila2026,
  author = {Mattila, Juho and Kallio, Johanna and Löyttyniemi, Eliisa and Nuutila, Pirjo and Koffert, Jukka},
  title = {Combined [18F]-FDG PET-MR imaging for monitoring small bowel crohn’s disease},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07524-4}
}
Kostenlos starten →